The Market Institute President Charles Sauer has submitted the following statement to Senate Committee on the Judiciary, Subcommittee on Intellectual Property for the Hearing on The Patent Trial and Appeal Board: Examining Proposals to Address Predictability, Certainty, and Fairness. June 22, 2022 The Market Institute advocates on behalf of small Read more…
The Market Institute President Charles Sauer has a new piece in the Washington Examiner’s Restoring America series on Standard Essential Patents. Excerpt below. “Sometimes, in Washington, D.C., it’s hard to figure out which side is the good side and which is the bad. It’s not an old Western film in Read more…
Market Institute President Charles Sauer has a new article out in Townhall on the State of the Union address and the inclusion of anti-innovation practices like price setting. Here’s an excerpt. “When the international community slapped sanctions on Putin’s Russia, many people cheered. Bad things were going to start happening Read more…
Market Institute President Charles Sauer has a new piece in RealClear Policy on patent rights. The White House recently issued a patent waiver for Covid-19 vaccines. Here’s an excerpt of Sauer’s article: “President Biden recently made what the Wall Street Journal referred to as the worst single Presidential decision since Nixon’s Read more…
Market Institute President Charles Sauer has a new article in the Washington Examiner on how government interference affects the development of new vaccines. Here’s an excerpt: “Vaccines are now being distributed around the world. However, the process is far from smooth, and many are getting frustrated. They should be. Israel Read more…
Market Institute President Charles Sauer has a new article up at the Washington Examiner on how the United States Patent and Trademark Office has empowered innovation the last 4 years. President Trump’s legacy will be something that is debated for years to come, but his administration did have some redeeming Read more…
The Market Institute’s Charles Sauer is out with a new Op-ed in the Washington Examiner looking at legislation on “Surprise Billing.” In the midst of intense negotiations on a phase 4 coronavirus relief bill, a debate is brewing over the inclusion of a ‘fix’ to the issue of surprise billing. Read more…